Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e31ed5008cb9c08509222a73e2c37282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f35441f7b9ac6d1c980854c8381b349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26f88d8c5b07cdcdc141943450f95802 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32622 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2007-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e919b48effc2259dae193ddc74c163f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08543604eede5ec4b9883442077063a5 |
publicationDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007087410-A2 |
titleOfInvention |
Novel recombinant t4 phage particle containing hiv, h. pylori or cancer antigens and uses thereto |
abstract |
The invention is directed to a novel recombinant T4 phage particle expressing a HOC and/or SOC Helicobacter pylori and/or SCLC fusion peptide as well as methods for their preparation and methods of use in compositions and kits. |
priorityDate |
2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |